Key facts, as of
As of November 6, 2026, Cardinal Health (CAH) trades at $271.72, up 37.2% over the past year. Its 52-week range runs from $180.45 to $286.29; the price is 5.1% below that high. It is 5.1% below its all-time high of $286.29, reached in November 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +380.1%, against +316.3% for the S&P 500 (SPY). It sits 21.6% above its 200-day average of $223.44, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 25.5% annualized, which we rate medium risk. It has a trailing P/E of 35.2 and a dividend yield of 0.76%.
Cite: Portfolio Terminal, "Cardinal Health (CAH) stock analysis", 2026-11-06. https://portfolio-terminal.com/analyse/cah
Where it trades today
trading 86% of the way up its 52-week range
How the price has moved
How far it is from its record
Cardinal Health (CAH) is 5.1% below its all-time high of $286.29, reached in November 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +380.1%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- CAH closes above its 50-day average ($240.48), and the 50-day sits above the 200-day ($223.44): on both averages the chart reads as an uptrend.
- At $271.72, CAH is 5.1% below its 1-year high of $286.29, set on November 5, 2026, and 50.6% above its 1-year low of $180.45 (May 13, 2026).
- Over the past month CAH rose 13.7%, from $238.96 to $271.72.
- CAH trades at 35.2x its last twelve months of earnings and 19.0x the next twelve months' estimate, so analysts expect earnings 84.9% higher.
- CAH's 30-day volatility, 25.5% a year, works out to a typical daily move of about 1.6%.
- Yahoo Finance puts its beta at 0.52: over five years of monthly returns, CAH moved about 0.52% for each 1% move of the S&P 500.
What would change the read
- A close under the 50-day average, $240.48 (−11.5% from the last close), would turn the read to a pullback; under the 200-day, $223.44 (−17.8%), the longer rise is in question.
- A close above $286.29 (+5.4%) would be a new 1-year high; below $180.45 (−33.6%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for CAH, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for CAH by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
What Cardinal Health does
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management…
Employees
58,788
Industry
Medical Distribution
Headquarters
Dublin, United States
What analysts expect
CAH carries a buy consensus from 15 analysts, with an average price target of $291.53 versus $271.72 today (+7.3%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CAH generated $257.75B in trailing revenue (5.5% year over year), with a 0.7% net margin, and $5.02B of free cash flow, against $3.55B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2026 | $254.25B | $9.77B | $3.17B | $1.71B | $7.27 | $4.53B |
| 2025 | $222.58B | $8.17B | $2.32B | $1.56B | $6.48 | $1.85B |
| 2024 | $226.83B | $7.41B | $2.13B | $852.00M | $3.48 | $3.25B |
| 2023 | $204.98B | $6.87B | $1.79B | $330.00M | $1.00 | $2.36B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
CAH is in 18 of the 54 ETFs we track. It weighs most in XLV: 0.92% of the fund, holding #26 of 62.
Famous investors who hold it
CAH is in the latest 13F of 2 of the 15 famous investors we follow. Renaissance Technologies (Founded by Jim Simons) holds the most of it: 0.18% of the portfolio, position #113 of 2,931, as of Q2 2026.
What the chart is saying
In an uptrend, 5.1% under its 1-year high with no resistance above.
uptrend- Price is 13.0% above its 50-day average and 21.6% above its 200-day.
- RSI at 74 is overbought: strong momentum, and stretched.
- Nothing above has stopped it this year; the nearest floor is $258.75 (-4.8%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is CAH valued right now?
Cardinal Health trades at 35.2 times its last twelve months of earnings and 19.0 times the next twelve months' estimate (Yahoo Finance, November 6, 2026). On the chart: in an uptrend, 5.1% under its 1-year high with no resistance above. Price is 13.0% above its 50-day average and 21.6% above its 200-day.
What is the risk level of CAH?
Based on 30-day volatility of 25.5%, CAH has MEDIUM risk. Its beta of 0.52 means it has swung less than the S&P 500 over the last five years.
Does CAH pay dividends?
Yes, Cardinal Health has a dividend yield of 0.76%.
How far is CAH from its all-time high?
Cardinal Health is 5.1% below its all-time high of $286.29, reached in November 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +380.1%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold CAH?
18 of the 54 popular ETFs we track hold Cardinal Health. The largest weights: XLV (0.92%), VO (0.51%), VIG (0.23%), VYM (0.22%) and RSP (0.21%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is CAH?
0.08%, as of September 30, 2026: CAH is holding #213 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.79 in Cardinal Health.
Which famous investors own CAH?
Renaissance Technologies (0.18% of Founded by Jim Simons's 13F) and Ray Dalio (0.13% of Bridgewater Associates's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for CAH?
The average analyst price target for Cardinal Health (CAH) is $291.53 based on 15 analyst estimates, about 7.3% above the current price of $271.72. The published range runs from $260.00 to $330.00.
How much revenue does CAH generate?
Cardinal Health reported $257.75B in trailing twelve-month revenue. Revenue growth is running at 5.5% year over year. Net margin sits at 0.7%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare CAH with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.
